The Trifluoperazine Hydrochloride Ta, cataloged under National Stock Number 6505-00-022-1336, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 4 specifications, cited from the U.S. Government catalog. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-00-022-1336 |
| Item Name | Trifluoperazine Hydrochloride Ta |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 1.000 MILLIGRAMS TRIFLUOPERAZINE EQUIVALENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Reference | Meaning |
|---|---|
| NDC00781-1030-10 | 3/9 Design control — primary reference Geneva Pharmaceuticals Inc |
NSN 6505-00-022-1336 is a Trifluoperazine Hydrochloride Ta, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-00-022-1336: Primary Container Content Quantity: 1000.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Active Medicament Medicinal Strength: 1.000 MILLIGRAMS TRIFLUOPERAZINE EQUIVALENT. 4 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.